News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
347,571 Results
Type
Article (16633)
Company Profile (130)
Press Release (330792)
Multimedia
Podcasts (96)
Webinars (22)
Section
Business (102162)
Career Advice (1352)
Deals (17008)
Drug Delivery (81)
Drug Development (37567)
Employer Resources (145)
FDA (6383)
Job Trends (8293)
News (165075)
Policy (13104)
Tag
2027 BioMidwest Elite (1)
2027 Bio NC Standard (1)
2027 Biotech Bay Elite (1)
2027 Biotech Bay Standard (2)
2027 Biotech Beach Elite (1)
2027 Genetown Elite (2)
2027 Genetown Standard (1)
2027 Pharm Country Elite (2)
2027 Pharm Country Standard (4)
Academia (1038)
Accelerated approval (27)
Adcomms (15)
Allergies (87)
Alliances (26667)
ALS (123)
Alzheimer's disease (968)
Antibody-drug conjugate (ADC) (303)
Approvals (6592)
Artificial intelligence (478)
Autoimmune disease (217)
Automation (45)
Bankruptcy (97)
Best Places to Work (6654)
BIOSECURE Act (19)
Biosimilars (100)
Biotechnology (110)
Bladder cancer (137)
Brain cancer (35)
Breast cancer (446)
Cancer (3384)
Cardiovascular disease (232)
Career advice (1174)
Career pathing (38)
CAR-T (219)
CDC (27)
Celiac Disease (1)
Cell therapy (617)
Cervical cancer (40)
Clinical research (34489)
Collaboration (1327)
Company closure (4)
Compensation (540)
Complete response letters (42)
COVID-19 (1175)
CRISPR (57)
C-suite (915)
Cystic fibrosis (76)
Data (4768)
Decentralized trials (1)
Denatured (35)
Depression (104)
Dermatology (51)
Diabetes (294)
Diagnostics (3080)
Digital health (30)
Diversity (7)
Diversity, equity & inclusion (32)
Drug discovery (236)
Drug pricing (136)
Drug shortages (20)
Duchenne muscular dystrophy (136)
Earnings (34152)
Editorial (57)
Employer branding (17)
Employer resources (122)
Events (52751)
Executive appointments (899)
FDA (8385)
Fibrodysplasia Ossificans Progressiva (6)
Friedreich's ataxia (14)
Frontotemporal dementia (25)
Funding (1042)
Gene editing (122)
Generative AI (52)
Gene therapy (442)
GLP-1 (584)
Government (1986)
Grass and pollen (3)
Guidances (253)
Healthcare (7709)
HIV (30)
Huntington's disease (42)
IgA nephropathy (68)
Immunology and inflammation (166)
Immuno-oncology (56)
Indications (107)
Infectious disease (1357)
Inflammatory bowel disease (148)
Inflation Reduction Act (11)
Influenza (82)
Intellectual property (156)
Interviews (209)
IPO (7078)
IRA (45)
Job creations (1860)
Job search strategy (988)
JPM (41)
Kidney cancer (15)
Labor market (91)
Layoffs (207)
Leadership (36)
Legal (2530)
Liver cancer (46)
Longevity (17)
Lung cancer (482)
Lymphoma (238)
Machine learning (47)
Management (45)
Manufacturing (728)
MASH (121)
Medical device (5514)
Medtech (5565)
Mergers & acquisitions (10816)
Metabolic disorders (798)
mRNA (108)
Multiple sclerosis (103)
NASH (9)
Neurodegenerative disease (233)
Neuropsychiatric disorders (62)
Neuroscience (1882)
Neurotech (1)
NextGen: Class of 2026 (3402)
Non-profit (1499)
Now hiring (34)
Obesity (367)
Opinion (273)
Ovarian cancer (146)
Pain (136)
Pancreatic cancer (165)
Parkinson's disease (236)
Partnered (24)
Patents (312)
Patient recruitment (356)
Peanut (32)
People (40318)
Pharmaceutical (19)
Pharmacy benefit managers (24)
Phase 1 (9604)
Phase 2 (15187)
Phase 3 (12839)
Pipeline (5322)
Policy (237)
Postmarket research (964)
Preclinical (4172)
Press Release (58)
Prostate cancer (183)
Psychedelics (32)
Radiopharmaceuticals (202)
Rare diseases (554)
Real estate (3614)
Recruiting (63)
Regulatory (11359)
Reports (40)
Research institute (1052)
Resumes & cover letters (216)
Rett syndrome (19)
RNA editing (10)
RSV (38)
Schizophrenia (109)
Series A (188)
Series B (141)
Service/supplier (4)
Sickle cell disease (45)
Special edition (21)
Spinal muscular atrophy (92)
Sponsored (32)
Startups (2070)
State (2)
Stomach cancer (10)
Supply chain (79)
Tariffs (83)
The Weekly (59)
Vaccines (402)
Venture capital (77)
Weight loss (227)
Women's health (57)
Worklife (18)
Date
Today (63)
Last 7 days (385)
Last 30 days (1779)
Last 365 days (16852)
2026 (7658)
2025 (16942)
2024 (19004)
2023 (21312)
2022 (29508)
2021 (30663)
2020 (28063)
2019 (24145)
2018 (18229)
2017 (16102)
2016 (14977)
2015 (17113)
2014 (12370)
2013 (10294)
2012 (11608)
2011 (12210)
2010 (10587)
Location
Africa (438)
Alabama (74)
Alaska (4)
Arizona (162)
Arkansas (7)
Asia (22880)
Australia (3871)
California (7536)
Canada (2145)
China (879)
Colorado (245)
Connecticut (335)
Delaware (205)
Europe (47576)
Florida (1079)
Georgia (196)
Hawaii (2)
Idaho (35)
Illinois (552)
India (53)
Indiana (415)
Iowa (17)
Japan (330)
Kansas (58)
Kentucky (23)
Louisiana (24)
Maine (19)
Maryland (839)
Massachusetts (5419)
Michigan (218)
Minnesota (397)
Mississippi (4)
Missouri (63)
Montana (19)
Nebraska (17)
Nevada (69)
New Hampshire (53)
New Jersey (1993)
New Mexico (19)
New York (2133)
North Carolina (1023)
North Dakota (10)
Northern California (3863)
Ohio (229)
Oklahoma (15)
Oregon (17)
Pennsylvania (1378)
Puerto Rico (17)
Rhode Island (23)
South America (636)
South Carolina (39)
Southern California (2921)
Tennessee (85)
Texas (1073)
United States (26174)
Utah (163)
Vermont (1)
Virginia (111)
Washington D.C. (33)
Washington State (737)
West Virginia (4)
Wisconsin (98)
347,571 Results for "biotechnology industry statistics".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Ansa Biotechnologies to Showcase Breakthrough DNA Synthesis Technology Backed by Industry’s Only On-Time Guarantee at SynBioBeta 2026 Conference
April 29, 2026
·
3 min read
Press Releases
Akebia Therapeutics Announces Vadadustat Post-hoc Win Statistics Analysis Demonstrating Statistically Significant Reduction in Mortality and Hospitalization Composite Endpoint Published in the Journal of American Society of Nephrology
May 4, 2026
·
10 min read
Press Releases
Systemic immune activation with eftilagimod alfa associated with statistically significant increased overall survival in late-stage cancer patients
May 28, 2026
·
4 min read
Press Releases
Insilico Medicine and Human Longevity Announce Collaboration to Co-Develop Industry-First AI Foundation Model for Longevity Science
May 26, 2026
·
5 min read
Press Releases
D&D Pharmatech Announces Positive 48-Week Histology Results for Zabopegdutide (DD01), Demonstrating Statistically Significant Fibrosis Improvement and MASH Resolution
May 27, 2026
·
6 min read
Press Releases
Synthekine Appoints Biotechnology and Pharmaceutical Industry Veteran John A. Orwin as Chair of its Board of Directors
February 23, 2026
·
2 min read
Press Releases
OS Therapies Appoints Biotech Industry Luminary Robert “Bob” S. Langer, PhD as Strategic Advisor
• Co-founder of more than 40 biotechnology companies, including 16 IPOs and 19 successful acquisitions • Scientific and medical titan focused on driving innovation for human health • Will assist with listeria oncology pipeline prioritization, combinations with other oncology-focused biotechnologies and tADC candidate selection for further development
April 13, 2026
·
8 min read
Press Releases
Daiichi Sankyo Showcases Progress Across Industry-Leading Oncology Portfolio with Latest Research Updates at ASCO
May 28, 2026
·
13 min read
Press Releases
Atropos Health Implements Industry-Leading Evidence Review Process to Ensure Quality and Accuracy of Evidence Generation at Scale
April 15, 2026
·
4 min read
Press Releases
Tovecimig Demonstrates Statistically Significant Benefit in COMPANION-002 Randomized Phase 2/3 Study in Patients with Biliary Tract Cancer
April 27, 2026
·
11 min read
1 of 34,758
Next
